Success Metrics

Clinical Success Rate
81.3%

Based on 13 completed trials

Completion Rate
81%(13/16)
Active Trials
15(31%)
Results Posted
54%(7 trials)
Terminated
3(6%)

Phase Distribution

Ph phase_1
2
4%
Ph phase_3
1
2%
Ph phase_4
1
2%
Ph phase_2
2
4%
Ph early_phase_1
1
2%
Ph not_applicable
41
85%

Phase Distribution

3

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution48 total trials
Early Phase 1First-in-human
1(2.1%)
Phase 1Safety & dosage
2(4.2%)
Phase 2Efficacy & side effects
2(4.2%)
Phase 3Large-scale testing
1(2.1%)
Phase 4Post-market surveillance
1(2.1%)
N/ANon-phased studies
41(85.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

68.4%

13 of 19 finished

Non-Completion Rate

31.6%

6 ended early

Currently Active

15

trials recruiting

Total Trials

48

all time

Status Distribution
Active(21)
Completed(13)
Terminated(6)
Other(8)

Detailed Status

Completed13
Recruiting11
unknown8
Not yet recruiting5
Active, not recruiting4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
48
Active
15
Success Rate
81.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.1%)
Phase 12 (4.2%)
Phase 22 (4.2%)
Phase 31 (2.1%)
Phase 41 (2.1%)
N/A41 (85.4%)

Trials by Status

enrolling_by_invitation12%
withdrawn36%
recruiting1123%
active_not_recruiting48%
completed1327%
not_yet_recruiting510%
terminated36%
unknown817%

Recent Activity

Clinical Trials (48)

Showing 20 of 48 trialsScroll for more
NCT06976840Not Applicable

Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments

Not Yet Recruiting
NCT05647044Phase 1

Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury

Recruiting
NCT07520630Not Applicable

Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke

Not Yet Recruiting
NCT07487454Not Applicable

Sham-Controlled Rapid-Acting Neuromodulation for Depression

Not Yet Recruiting
NCT05607121Not Applicable

TMS Visual Modulation in Body Dysmorphic Disorder

Completed
NCT07452939Not Applicable

Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium

Recruiting
NCT04684706Not Applicable

Compressed Intermittent Theta Burst Stimulation

Active Not Recruiting
NCT05322239Not Applicable

Resting State Changes Following Theta Burst Stimulation

Recruiting
NCT07026461Phase 4

Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression

Recruiting
NCT05591677Phase 2

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)

Active Not Recruiting
NCT07073235Not Applicable

Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Lower Extremity in Chronic Stroke Patients

Recruiting
NCT07073248Not Applicable

Effects of Intermitted Theta Burst Stimulation (iTBS) on Motor Recovery of Upper Extremity in Chronic Stroke Patients

Recruiting
NCT07188376Not Applicable

Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation

Recruiting
NCT07181226Not Applicable

High-Frequency vs. Theta-Burst TMS for Depression

Completed
NCT04846829Early Phase 1

Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)

Active Not Recruiting
NCT07158567Phase 3

Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT

Not Yet Recruiting
NCT06999304Not Applicable

Pilot TMS in Mild TBI

Enrolling By Invitation
NCT05578209Not Applicable

Therapeutic Impacts of Theta Burst Stimulation Over Bilateral Posterior Superior Temporal Sulcus in Autism Spectrum Disorder

Active Not Recruiting
NCT05860647Not Applicable

Transmagnetic Stimulation Pilot in Primary Progressive Aphasia

Completed
NCT06974838Not Applicable

Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
48